Please assess the completion status of the following clinical trial:

Trial Title: Safety and Efficacy of Cryoablation for Abdominal Pain Associated With Pancreatic Cancer

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Subject must be at least 18 years old~* Subject has unresectable or inoperable pancreatic carcinoma as determined by CT or MRI~* Subject's epigastric/abdominal 'worst pain' in the last 24 hours must be reported to be 4 or above on a scale of 0 (no pain) to 10 (pain as bad as subject can imagine) on the BPI despite pharmaceutical pain management~* ECOG of 0-3~* Platelet count \>50,000~* INR \<1.5~Exclusion Criteria:~* Subject's life expectancy is \<3 months~* Subject has current neutropenia (ANC \<1000)~* Subject unable to undergo CT or MRI~* Subject had previous ETOH neurolytic block for pancreatic cancer-related pain less than 2 weeks from screening~* Subject had surgery \<4 weeks from screening

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Cryoablation (Type: OTHER): Freezing of the celiac plexus

Based on this trial design, predict the completion outcome and termination type (if applicable).